Widaplik is indicated for the treatment of hypertension, including as initial treatment, to lower blood pressure.

(mean 6.3); 82 patients were randomized to memantine (10 mg/day) and 84 were randomized to placebo. Overall outcomes significantly favored the treatment group on measures of global assessment and ...